Puntillo Melisa, Segli Franco, Champagne Claude P, Raymond Yves, Vinderola Gabriel
Instituto de Lactología Industrial (CONICET-UNL), Facultad de Ingeniería Química, Universidad Nacional del Litoral, Santa Fe, Argentina; email:
Centro de Referencia para Lactobacilos (CERELA-CONICET), Tucumán, Argentina.
Annu Rev Food Sci Technol. 2022 Mar 25;13:385-407. doi: 10.1146/annurev-food-052720-011545.
Life expectancy has dramatically increased over the past 200 years, but modern life factors such as environmental exposure, antibiotic overuse, C-section deliveries, limited breast-feeding, and diets poor in fibers and microbes could be associated with the rise of noncommunicable diseases such as overweight, obesity, diabetes, food allergies, and colorectal cancer as well as other conditions such as mental disorders. Microbial interventions that range from transplanting a whole undefined microbial community from a healthy gut to an ill one, e.g., so-called fecal microbiota transplantation or vaginal seeding, to the administration of selected well-characterized microbes, either live (probiotics) or not (postbiotics), with efficacy demonstrated in clinical trials, may be effective tools to treat or prevent acute and chronic diseases that humans still face, enhancing the quality of life.
在过去的200年里,人类预期寿命显著提高,但现代生活中的一些因素,如环境暴露、抗生素过度使用、剖宫产、母乳喂养不足以及膳食纤维和微生物含量低的饮食,可能与超重、肥胖、糖尿病、食物过敏和结直肠癌等非传染性疾病的增加以及精神障碍等其他疾病有关。微生物干预措施多种多样,从将整个未定义的微生物群落从健康肠道移植到患病肠道(例如所谓的粪便微生物群移植或阴道接种),到施用经过精心表征的选定微生物,无论是活的(益生菌)还是非活的(后生元),且已在临床试验中证明其有效性,这些措施可能是治疗或预防人类仍然面临的急慢性疾病、提高生活质量的有效工具。